Forty-two patients with previously untreated peripheral T-cell lymphomas (PTCL) were treated with an intensive chemothcrapy protocol. Either the BACOP or the m-BACOD regimen was used for induction. Patients achieving complete clinical remission after three courses were given intensive consolidation
The prognostic factors for peripheral T-cell lymphomas
โ Scribed by Dr Raymond Liang; S. L. Loke; A. C. L. Chan
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 369 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0278-0232
No coin nor oath required. For personal study only.
โฆ Synopsis
The peripheral T-cell lymphomas of 50 patients were classified by histological type and tumour cell size, the latter as described by the Nebraska Group. There was no difference in the pattern of their clinical features among the various histological subtypes and their clinical outcome was similar. Cell size and other factors including sex, age, presence of B symptoms, sites of primary disease, histological subtypes according to the Japanese classification, lactate dehydrogenase level and presence of bulky disease did not appear to correlate with clinical outcome. However, patients with stage IV disease had significantly lower CR rate (9j29 versus 16/21,p=0.01) and poorer survival at 3 years (p=O.O5) than those with stage I, I1 and 111 disease. Patients receiving COPP, the less intensive chemotherapy regimen, appeared to have poorer clinical outcome but the difference observed was not statistically significant because of the number of patients in each subgroup.
๐ SIMILAR VOLUMES